Arca
Skip to content
Tools
Tools

Bevacizumab 1.25 MG/0.05 ML Solution for Injection

Recall D-0050-2024, part of FDA recall event 93154. See Pine Pharmaceuticals's company page.

Pine Pharmaceuticals, LLC started this Class II drug recall on Oct 2, 2023 (voluntary: firm initiated); FDA lists it as terminated, terminated May 15, 2024.

  • Classification: Class II
  • Started: Oct 2, 2023
  • Status: Terminated
  • Products in this event: 16

Why It Was Recalled

Class II

Lack of Assurance of Sterility

Record

Product
Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Quantity
2862 Syringes
Lots and codes
Lot #: 68622, 68620 Exp. Date 10/3/2023; 68632 Exp. Date 10/4/2023; 68699, 68704, 68706 Exp. Date 10/6/2023; 68726, 68740 Exp. Date 10/7/2023; 68784 Exp. Date 10/11/2023; 68843, 68861, Exp. Date 10/13/2023; 68789,68822 Exp. Date 10/12/2023; 68914 Exp. Date 10/17/2023; 68952, 68954, 68980 Exp. Date 10/18/2023; 69105 Exp. Date 10/25/2023; 69731 Exp. Date 11/7/2023; 69991 Exp. Date 11/15/2023;70142 Exp. Date 11/22/2023; 70233 Exp. Date 11/28/2023; 70297, 70264, 70291, 70300 Exp. Date 11/30/2023; 70355 Exp. Date 12/5/2023; 70516, 70513 Exp. Date 12/12/2023;;70659, 70664 Exp. Date 12/19/2023;…
Distribution
Nationwide within the United States
Recalling firm
Pine Pharmaceuticals, LLC, Tonawanda, NY, United States
How the firm notified
Letter
FDA classified
Oct 19, 2023

Other Products in This Recall

Recall event 93154

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.